Volume 16, Number 10—October 2010
Dispatch
Severe Plasmodium vivax Malaria, Brazilian Amazon
Table 1
Patient no. | Year | Age/sex | WHO severity criterion | Duration of disease, d | Antimicrobial drug use | Erythrocyte transfusion | Concurrent condition | ICU | Death |
---|---|---|---|---|---|---|---|---|---|
1 | 2001 | 2 y/F | Severe anemia† | 4 | No | Yes | – | No | No |
2 | 2001 | 9 mo/M | Severe anemia† | 10 | No | Yes | – | No | No |
3 | 2001 | 3 y/F | Jaundice‡ | 3 | No | No | HAV | No | No |
4 | 2001 | 60 y/F | Acute renal failure§ | 7 | No | No | Arterial hypertension | No | No |
5 | 2001 | 1 mo/M | Severe anemia† | 3 | No | Yes | – | No | No |
6 | 2001 | 40 y/M | Jaundice‡ | 9 | No | No | – | No | No |
7 | 2001 | 80 y/M | Acute renal failure§ | 6 | No | No | – | No | No |
8 | 2002 | 7 y/M | Hemoglobinuria/ jaundice‡ | 4 | No | Yes | – | No | No |
9 | 2002 | 5 mo/M | Severe anemia†/ ARDS | 3 | No | Yes | – | No | No |
10 | 2002 | 28 d/M | Jaundice‡ | 5 | No | No | – | No | No |
11 | 2002 | 46 y/F | Severe anemia†/ ARDS | 5 | No | Yes | – | Yes | Yes |
12 | 2002 | 48 y/F | Jaundice‡ | 7 | No | No | – | No | No |
13 | 2002 | 58 y/M | Jaundice‡ | 12 | No | No | Diabetes | No | No |
14 | 2002 | 47 y/F | Jaundice‡ | 8 | No | No | – | No | No |
15 | 2002 | 43 y/F | Shock¶/jaundice | 4 | Yes | Yes | – | Yes | No |
16 | 2002 | 34 y/M | Jaundice | 10 | No | No | – | No | No |
17 | 2002 | 50 y/M | Jaundice | 7 | No | No | – | No | No |
*WHO, World Health Organization; ICU, intensive care unit; HAV, hepatitis A virus; ARDS, acute respiratory distress syndrome (tachypnea, shortness of breath, and signs of hypoxemia).
†Hemoglobin <7 g/dL in adults and <5 g/dL in children.
‡Total bilirubin >3.0 mg/dL.
§Creatinine >3.0 mg/dL.
¶Systolic arterial tension <80 mm Hg despite fluid therapy.
Page created: September 07, 2011
Page updated: September 07, 2011
Page reviewed: September 07, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.